The cerebral cortex: a case for a common site of action of antipsychotics
Open Access
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 19 (4), 136-140
- https://doi.org/10.1016/s0165-6147(98)01186-9
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Clozapine occupies high levels of dopamine D2 receptorsLife Sciences, 1997
- The role of cognition in the risk‐benefit and safety analysis of antipsychotic medicationActa Psychiatrica Scandinavica, 1996
- Effects of Olanzapine on Regional C-Fos Expression in Rat ForebrainNeuropsychopharmacology, 1996
- The Effects of Dopamine on the Subthreshold Electrophysiological Responses of Rat Prefrontal Cortex Neurons In VitroEuropean Journal of Neuroscience, 1995
- Biochemical Findings of Negative Symptoms in Schizophrenia and Their Putative Relevance to Pharmacological TreatmentNeuropsychobiology, 1994
- D1/D2 dopamine receptor interaction at the biochemical levelTrends in Pharmacological Sciences, 1991
- Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in ratsJournal of Neural Transmission, 1990
- Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkageActa Psychiatrica Scandinavica, 1990
- Schizophrenic syndromes, cognitive performance and neurological dysfunctionPsychological Medicine, 1987
- Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease processLife Sciences, 1978